uniQure (QURE) Other financing activities (2018 - 2026)
uniQure's (QURE) quarterly Other financing activities came in at $550000.0 in Q1 2026, up 245.91% year-on-year from $159000.0 in Q1 2025, and down 97.64% quarter-over-quarter from $23.3 million in Q3 2025.
uniQure (QURE) Other financing activities (2018 - 2026) Analysis & Trends
uniQure's Other financing activities history runs 9 years deep, the most recent figure standing at $550000.0 for Q1 2026.
- On a quarterly basis, Other financing activities rose 245.91% year-over-year to $550000.0 in Q1 2026; TTM through Mar 2026 was $23.9 million, a 948.73% increase from a year earlier, with the FY2025 full-year figure at $23.5 million, up 1006.88% from the prior year.
- Other financing activities slipped to $550000.0 in Q1 2026 per QURE's latest filing, from $23.3 million in the prior quarter.
- Across five years, Other financing activities topped out at $23.3 million in Q3 2025 and bottomed at $31000.0 in Q3 2024.
- The 5-year median for Other financing activities is $145000.0 (2023), against an average of $2.0 million.
- Across the five-year window, Other financing activities sank 92.35% in 2023 and jumped 75048.39% in 2025, its largest moves.
- Year by year, Other financing activities stood at $601000.0 in 2022, then slumped by 92.35% to $46000.0 in 2023, then surged by 4339.13% to $2.0 million in 2024, then surged by 1040.84% to $23.3 million in 2025, then slumped by 97.64% to $550000.0 in 2026.
- Per Business Quant, the three latest QURE Other financing activities figures stand at $550000.0 (Q1 2026), $23.3 million (Q3 2025), and $44000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 550,000.00 |
| Mar 31, 2026 | 550,000.00 |
| Sep 30, 2025 | 23.30 Mn |
| Sep 30, 2025 | 23.30 Mn |
| Jun 30, 2025 | 44,000.00 |
| Jun 30, 2025 | 44,000.00 |
| Mar 31, 2025 | 159,000.00 |
| Mar 31, 2025 | 159,000.00 |
| Dec 31, 2024 | 2.04 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 31,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | 56,000.00 |
| Sep 30, 2023 | 56,000.00 |
| Jun 30, 2023 | 75,000.00 |
| Jun 30, 2023 | 75,000.00 |
| Mar 31, 2023 | 131,000.00 |
| Mar 31, 2023 | 131,000.00 |